Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
In the Pharmaceuticals & Drugs sector, Hindustan Bio Sciences Ltd. exhibits concerning financial metrics, with no growth, profitability, or efficiency indicators, making it a significant underperformer compared to its peers. Companies like Cipla Ltd. and Dr. Reddy's Laboratories Ltd. stand out as strong performers with robust profitability and attractive valuations.
Highest revenue growth (YoY), strong ROE of 16.63%, attractive PE ratio of 23.73.
Strong EPS growth, highest ROE and ROCE in the peer group.